Publication | Closed Access

Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel

Breast OncologyMedicineAdjuvant ChemotherapyGenetic VariabilityBreast CancerPharmacotherapyTreatment-related FactorsCancer TreatmentOncologyRadiation Oncology